Anti-EST1/ CES1/ ACAT functional antibody

Anti-EST1/ CES1/ ACAT functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CES1/CES1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T76369-Ab-1/ GM-Tg-hg-T76369-Ab-2Anti-Human CES1 monoclonal antibodyHuman
GM-Tg-rg-T76369-Ab-1/ GM-Tg-rg-T76369-Ab-2Anti-Rat CES1 monoclonal antibodyRat
GM-Tg-mg-T76369-Ab-1/ GM-Tg-mg-T76369-Ab-2Anti-Mouse CES1 monoclonal antibodyMouse
GM-Tg-cynog-T76369-Ab-1/ GM-Tg-cynog-T76369-Ab-2Anti-Cynomolgus/ Rhesus macaque CES1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T76369-Ab-1/ GM-Tg-felg-T76369-Ab-2Anti-Feline CES1 monoclonal antibodyFeline
GM-Tg-cang-T76369-Ab-1/ GM-Tg-cang-T76369-Ab-2Anti-Canine CES1 monoclonal antibodyCanine
GM-Tg-bovg-T76369-Ab-1/ GM-Tg-bovg-T76369-Ab-2Anti-Bovine CES1 monoclonal antibodyBovine
GM-Tg-equg-T76369-Ab-1/ GM-Tg-equg-T76369-Ab-2Anti-Equine CES1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T76369-Ab-1/ GM-Tg-hg-T76369-Ab-2; GM-Tg-rg-T76369-Ab-1/ GM-Tg-rg-T76369-Ab-2;
GM-Tg-mg-T76369-Ab-1/ GM-Tg-mg-T76369-Ab-2; GM-Tg-cynog-T76369-Ab-1/ GM-Tg-cynog-T76369-Ab-2;
GM-Tg-felg-T76369-Ab-1/ GM-Tg-felg-T76369-Ab-2; GM-Tg-cang-T76369-Ab-1/ GM-Tg-cang-T76369-Ab-2;
GM-Tg-bovg-T76369-Ab-1/ GM-Tg-bovg-T76369-Ab-2; GM-Tg-equg-T76369-Ab-1/ GM-Tg-equg-T76369-Ab-2
Products NameAnti-CES1 monoclonal antibody
Formatmab
Target NameCES1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CES1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T76369-Ag-1Recombinant multi-species EST1/ CES1/ ACAT protein


    Target information

    Target IDGM-T76369
    Target NameCES1
    Gene ID1066,403643,493774
    Gene Symbol and SynonymsACAT,CE-1,CEH,CES-K1,CES1,CES2,CESDD1,hCE-1,HMSE,HMSE1,PCE-1,REH,SES1,TGH
    Uniprot AccessionP23141
    Uniprot Entry NameEST1_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000198848
    Target ClassificationN/A

    The target: CES1, gene name: CES1, also named as ACAT, CE-1, CEH, CES2, HMSE, HMSE1, PCE-1, REH, SES1, TGH, hCE-1. This gene encodes a member of the carboxylesterase large family. The family members are responsible for the hydrolysis or transesterification of various xenobiotics, such as cocaine and heroin, and endogenous substrates with ester, thioester, or amide bonds. They may participate in fatty acyl and cholesterol ester metabolism, and may play a role in the blood-brain barrier system. This enzyme is the major liver enzyme and functions in liver drug clearance. Mutations of this gene cause carboxylesterase 1 deficiency. Three transcript variants encoding three different isoforms have been found for this gene. [provided by RefSeq, Jun 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.